12/25/2019CDE Solicits Comments on Guidelines for Clinical Protocol of Biosimila...

12/23/2019NMPA Issues the Technical Guidelines for Clinical Comparability Studie...

12/23/2019BeiGene Announces Acceptance of a China sNDA for REVLIMID in Relapsed ...

12/23/2019Chinese Medical Researcher Investigated for Smuggling Vials of Biologi...

12/23/2019AZ's Triple-Combination Therapy Approved in China

12/23/2019Amid Trade War, China Lowers Import Tariffs on 850 Products Including ...

12/23/2019Roche Eyes China for Sarepta's DMD Gene Therapy

12/20/2019Chi-Med Gets Priority Review for 'Surufatinib' in China

12/20/2019Gilead Sciences Announces Chinese Approval of Chronic HCV Drug Vosevi

12/20/2019InxMed Cleared to Initiate Phase I Trial for Anticancer FAK Inhibitor

12/20/2019China's Largest Plasmid and Virus Facility from GenScript Operational

12/20/2019TRACON, 3D Medicines and Alphamab Enter Partnership for Subcutaneous P...

12/20/2019NHC Issues Clinical Application Guidelines for New Anticancers

12/20/2019Wuxi Biologics and Convalife Form Partnership to Develop Innovative An...

12/19/2019Genzyme's Orphan Drug Fabrazyme (Agalsidase Beta) Approved in China

12/19/2019Van Andel to Pay $5.5M for Failing to Disclose Chinese Funding

12/19/2019George Clinical and GDPH to Collaborate in Clinical Research

12/19/2019Shanghai Launches New "Cell Factory" for Cancer Therapy

12/19/2019Recent Announcement for A More Effective Intellectual Property Protect...

12/19/2019PHIIC: Data Snapshots of Chinese Pharma Market 2013-2019E

12/19/2019Performance Snapshots of HKSE-Listed Pre-profit Biotech Startups

12/19/2019NHC Issues Notice to Facilitate Inventory and Use of Tender Prevailing...

12/19/2019Shanghai Launches New Policy to Support Building of Research Hospitals

12/18/2019Everest Medicines Announces Chinese Clinical Trial Approval of Nefecon...

12/18/2019Moffitt Cancer Center CEO, Others Resign Over China Ties

12/18/2019Abcodia and AstraZeneca China Form Strategic Alliance for Ovarian Canc...

12/18/2019Chinese Cancer Drug Market to Surpass $30+ Billion by 2025

12/18/2019HitGen and Mitsubishi Tanabe Enter Into License Agreement

12/18/2019Takeda Aspires to Become A Top Ten MNC Pharma Co. in China

12/17/2019Frontage Acquires CRO BRI Biopharma for Expansion into North America

Page:269/789 Total number of articles:23668: [First][<<] [267] [268] [269] [270] [271] [>>] [End]